John Gold - Publications

Affiliations: 
University of California, Davis, Davis, CA 

258 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bansal S, Bae GY, Frankovich K, Robinson BM, Leonard CJ, Gold JM, Luck SJ. Increased repulsion of working memory representations in schizophrenia. Journal of Abnormal Psychology. PMID 32881536 DOI: 10.1037/Abn0000637  0.367
2020 Dwyer KR, Andrea AM, Savage CLG, Orth RD, Shan L, Strauss GP, Adams HA, Kelly DL, Weiner E, Gold JM, McMahon RP, Carpenter WT, Buchanan RW, Blanchard JJ. A Randomized Clinical Trial of Oxytocin or Galantamine in Schizophrenia: Assessing the Impact on Behavioral, Lexical, and Self-Report Indicators of Social Affiliation. Schizophrenia Bulletin Open. 1: sgaa001. PMID 32803156 DOI: 10.1093/schizbullopen/sgaa001  0.336
2020 Moran EK, Gold JM, Carter CS, MacDonald AW, Ragland JD, Silverstein SM, Luck SJ, Barch DM. Both unmedicated and medicated individuals with schizophrenia show impairments across a wide array of cognitive and reinforcement learning tasks. Psychological Medicine. 1-11. PMID 32799938 DOI: 10.1017/S003329172000286X  0.461
2020 Buchanan RW, Weiner E, Kelly DL, Gold JM, Chen S, Zaranski J, Blatt F, Wehring H, Carpenter WT. Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia. Journal of Clinical Psychopharmacology. PMID 32796391 DOI: 10.1097/Jcp.0000000000001253  0.39
2020 Bansal S, Gaspar JM, Robinson BM, Leonard CJ, Hahn B, Luck SJ, Gold JM. Antisaccade Deficits in Schizophrenia Can Be Driven by Attentional Relevance of the Stimuli. Schizophrenia Bulletin. PMID 32766726 DOI: 10.1093/Schbul/Sbaa106  0.329
2020 Gold JM, Bansal S, Anticevic A, Cho YT, Repovš G, Murray JD, Hahn B, Robinson BM, Luck SJ. Refining the Empirical Constraints on Computational Models of Spatial Working Memory in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32741701 DOI: 10.1016/J.Bpsc.2020.05.003  0.366
2020 Culbreth AJ, Waltz JA, Frank MJ, Gold JM. Retention of Value Representations Across Time in People With Schizophrenia and Healthy Control Subjects. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32712211 DOI: 10.1016/J.Bpsc.2020.05.009  0.349
2020 Gold JM, Corlett PR, Strauss GP, Schiffman J, Ellman LM, Walker EF, Powers AR, Woods SW, Waltz JA, Silverstein SM, Mittal VA. Enhancing Psychosis Risk Prediction Through Computational Cognitive Neuroscience. Schizophrenia Bulletin. PMID 32648913 DOI: 10.1093/Schbul/Sbaa091  0.389
2020 Hahn B, Bae GY, Robinson BM, Leonard CJ, Luck SJ, Gold JM. Cortical hyperactivation at low working memory load: A primary processing abnormality in people with schizophrenia? Neuroimage. Clinical. 26: 102270. PMID 32388334 DOI: 10.1016/J.Nicl.2020.102270  0.396
2020 Leonard CJ, Robinson BM, Hahn B, Gold JM, Luck SJ. Increased influence of a previously attended feature in people with schizophrenia. Journal of Abnormal Psychology. 129: 305-311. PMID 32212750 DOI: 10.1037/Abn0000511  0.417
2020 Kraus MS, Gold JM, Barch DM, Walker TM, Chun CA, Buchanan RW, Csernansky JG, Goff DC, Green MF, Jarskog LF, Javitt DC, Kimhy D, Lieberman JA, McEvoy JP, Mesholam-Gately RI, et al. The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures. Schizophrenia Research. Cognition. 19: 100161. PMID 31832342 DOI: 10.1016/J.Scog.2019.100161  0.431
2020 Waltz JA, Wilson RC, Albrecht MA, Frank MJ, Gold JM. Differential Effects of Psychotic Illness on Directed and Random Exploration Computational Psychiatry. 4: 18-39. DOI: 10.1162/cpsy_a_00027  0.301
2020 Ponomareva OY, Redman B, Sayer MA, Wehring HJ, Vyas G, Richardson CM, Gold JM, Gorelick DA, Cihakova D, Talor MV, Hoag SW, Buchanan RW, Wang J, Chen S, Liu F, et al. L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia Schizophrenia Bulletin Open. 1. DOI: 10.1093/SCHIZBULLOPEN/SGAA026  0.327
2020 Waltz J, Hernaus D, Wilson R, Brown E, Frank M, Gold J. T62. A COMPUTATIONAL ANALYSIS OF MOTIVATIONAL DEFICITS IN SCHIZOPHRENIA SPECTRUM DISORDERS Schizophrenia Bulletin. 46: S255-S255. DOI: 10.1093/Schbul/Sbaa029.622  0.317
2020 Culbreth A, Waltz J, Frank M, Gold J. Negative Symptoms in People With Schizophrenia are Associated With Reduced Long-Term Retention of Reward Information Biological Psychiatry. 87: S310-S311. DOI: 10.1016/J.Biopsych.2020.02.800  0.304
2020 Hahn B, Robinson B, Luck S, Gold J. Neural Mechanisms of Selective Attention Deficits in People With Schizophrenia Biological Psychiatry. 87: S203-S204. DOI: 10.1016/J.Biopsych.2020.02.529  0.345
2019 Luck SJ, Hahn B, Leonard CJ, Gold JM. The Hyperfocusing Hypothesis: A New Account of Cognitive Dysfunction in Schizophrenia. Schizophrenia Bulletin. PMID 31317191 DOI: 10.1093/Schbul/Sbz063  0.512
2019 Luck SJ, Leonard CJ, Hahn B, Gold JM. Is Attentional Filtering Impaired in Schizophrenia? Schizophrenia Bulletin. PMID 31206163 DOI: 10.1093/Schbul/Sbz045  0.358
2019 Gold JM, Bansal S, Gaspar JM, Chen S, Robinson BM, Hahn B, Luck SJ. People with schizophrenia show enhanced cognitive costs of maintaining a single item in working memory. Psychological Medicine. 1-7. PMID 31088582 DOI: 10.1017/S0033291719000862  0.459
2019 Smucny J, Iosif AM, Eaton NR, Lesh TA, Ragland JD, Barch DM, Gold JM, Strauss ME, MacDonald AW, Silverstein SM, Carter CS. Latent Profiles of Cognitive Control, Episodic Memory, and Visual Perception Across Psychiatric Disorders Reveal a Dimensional Structure. Schizophrenia Bulletin. PMID 30953588 DOI: 10.1093/Schbul/Sbz025  0.359
2019 Kelly DL, Demyanovich HK, Rodriguez KM, Ciháková D, Talor MV, McMahon RP, Richardson CM, Vyas G, Adams HA, August SM, Fasano A, Cascella NG, Feldman SM, Liu F, Sayer MA, ... Gold JM, et al. Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study Journal of Psychiatry & Neuroscience : Jpn. 44: 1-9. PMID 30938127 DOI: 10.1503/Jpn.180174  0.327
2019 Strauss GP, Chapman HC, Keller WR, Koenig JI, Gold JM, Carpenter WT, Buchanan RW. Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia. Journal of Psychiatric Research. 112: 38-43. PMID 30849617 DOI: 10.1016/J.Jpsychires.2019.02.017  0.397
2019 Smucny J, Barch DM, Gold JM, Strauss ME, MacDonald AW, Boudewyn MA, Ragland JD, Silverstein SM, Carter CS. Cross-diagnostic analysis of cognitive control in mental illness: Insights from the CNTRACS consortium. Schizophrenia Research. PMID 30704863 DOI: 10.1016/J.Schres.2019.01.018  0.353
2019 Gold J, Bansal S, Hahn B, Robinson B, Luck S. O4.3. PEOPLE WITH SCHIZOPHRENIA SHOW GREATER COGNITIVE COSTS OF STORING A SINGLE ITEM IN WORKING MEMORY Schizophrenia Bulletin. 45: S169-S170. DOI: 10.1093/Schbul/Sbz021.203  0.379
2019 Waltz J, Hernaus D, Nassar M, Ritz H, Xu Z, Frank M, Ruiz R, Gold J. S45. DEFICITS IN INFORMATION-SEEKING BEHAVIOR IN SCHIZOPHRENIA: AN ALTERNATIVE MECHANISM OF AVOLITION Schizophrenia Bulletin. 45: S323-S323. DOI: 10.1093/Schbul/Sbz020.590  0.336
2019 Bansal S, Bae G, Robinson BR, Luck SJ, Gold J. S41. INFLUENCE OF PRIORS ON MOTION PERCEPTION IN SCHIZOPHRENIA Schizophrenia Bulletin. 45: S321-S322. DOI: 10.1093/Schbul/Sbz020.586  0.301
2019 Hernaus D, Gold J, Waltz J, Frank M. Converging evidence linking reinforcement learning deficits in schizophrenia to impairments in the representation of expected value European Neuropsychopharmacology. 29: S402-S403. DOI: 10.1016/J.Euroneuro.2018.11.609  0.364
2018 Hernaus D, Frank MJ, Brown EC, Brown JK, Gold JM, Waltz JA. Impaired Expected Value Computations in Schizophrenia Are Associated With a Reduced Ability to Integrate Reward Probability and Magnitude of Recent Outcomes. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 30683607 DOI: 10.1016/J.Bpsc.2018.11.011  0.326
2018 Gold JM, Barch DM, Feuerstahler LM, Carter CS, MacDonald AW, Ragland JD, Silverstein SM, Strauss ME, Luck SJ. Working Memory Impairment Across Psychotic disorders. Schizophrenia Bulletin. PMID 30260448 DOI: 10.1093/Schbul/Sby134  0.337
2018 Strauss GP, Granholm E, Holden JL, Ruiz I, Gold JM, Kelly DL, Buchanan RW. The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia. Psychological Medicine. 1-9. PMID 30180918 DOI: 10.1017/S0033291718002465  0.43
2018 Oliver LD, Haltigan JD, Gold JM, Foussias G, DeRosse P, Buchanan RW, Malhotra AK, Voineskos AN. Lower- and Higher-Level Social Cognitive Factors Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls: Relationship With Neurocognition and Functional Outcome. Schizophrenia Bulletin. PMID 30107517 DOI: 10.1093/Schbul/Sby114  0.433
2018 Hahn B, Robinson BM, Leonard CJ, Luck SJ, Gold JM. Posterior Parietal Cortex Dysfunction is Central to Working Memory Storage and Broad Cognitive Deficits in Schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30104335 DOI: 10.1523/Jneurosci.0913-18.2018  0.465
2018 Catalano LT, Heerey EA, Gold JM. The valuation of social rewards in schizophrenia. Journal of Abnormal Psychology. 127: 602-611. PMID 30102066 DOI: 10.1037/Abn0000366  0.301
2018 Viviano JD, Buchanan RW, Calarco N, Gold JM, Foussias G, Bhagwat N, Stefanik L, Hawco C, DeRosse P, Argyelan M, Turner J, Chavez S, Kochunov P, Kingsley P, Zhou X, et al. Resting-State Connectivity Biomarkers of Cognitive Performance and Social Function in Individuals With Schizophrenia Spectrum Disorder and Healthy Control Subjects. Biological Psychiatry. PMID 29779671 DOI: 10.1016/J.Biopsych.2018.03.013  0.452
2018 Hernaus D, Gold JM, Waltz JA, Frank MJ. Impaired Expected Value Computations Coupled With Overreliance on Stimulus-Response Learning in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 29735404 DOI: 10.1016/J.Bpsc.2018.03.014  0.361
2018 Albrecht MA, Waltz JA, Cavanagh JF, Frank MJ, Gold JM. Increased conflict-induced slowing, but no differences in conflict-induced positive or negative prediction error learning in patients with schizophrenia. Neuropsychologia. PMID 29709580 DOI: 10.1016/J.Neuropsychologia.2018.04.031  0.309
2018 Waltz JA, Xu Z, Brown EC, Ruiz RR, Frank MJ, Gold JM. Motivational Deficits in Schizophrenia Are Associated With Reduced Differentiation Between Gain and Loss-Avoidance Feedback in the Striatum. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 239-247. PMID 29486865 DOI: 10.1016/J.Bpsc.2017.07.008  0.355
2018 Oliver L, Haltigan J, Gold J, Foussias G, DeRosse P, Buchanan R, Malhotra A, Voineskos A. S245. LOWER- AND HIGHER-LEVEL SOCIAL COGNITIVE FACTORS ACROSS INDIVIDUALS WITH SCHIZOPHRENIA SPECTRUM DISORDERS AND HEALTHY CONTROLS: RELATIONSHIP WITH NEUROCOGNITION AND FUNCTIONAL OUTCOME Schizophrenia Bulletin. 44: S422-S422. DOI: 10.1093/schbul/sby018.1032  0.407
2018 Czepielewski L, Gama C, Carter C, MacDonald A, Gold J, Silverstein S, Barch D. T68. DIFFERENT INFLUENCES OF INTELLECTUAL FUNCTIONING AND COGNITIVE PERFORMANCE TO FUNCTIONAL OUTCOMES IN SCHIZOPHRENIA AND HEALTHY CONTROLS Schizophrenia Bulletin. 44: S140-S140. DOI: 10.1093/Schbul/Sby016.344  0.431
2018 Oliver L, Haltigan J, Gold J, Foussias G, DeRosse P, Buchanan R, Malhotra A, Voineskos A. S189. Lower- and Higher-Level Factors of Social Cognition Relate to Neurocognition and Functional Outcome Across Schizophrenia Spectrum Disorders and Healthy Controls Biological Psychiatry. 83: S420-S421. DOI: 10.1016/J.Biopsych.2018.02.1081  0.409
2017 Gold JM, Robinson B, Leonard CJ, Hahn B, Chen S, McMahon RP, Luck SJ. Selective Attention, Working Memory, and Executive Function as Potential Independent Sources of Cognitive Dysfunction in Schizophrenia. Schizophrenia Bulletin. PMID 29140504 DOI: 10.1093/Schbul/Sbx155  0.421
2017 Reddy LF, Horan WP, Barch DM, Buchanan RW, Gold JM, Marder SR, Wynn JK, Young J, Green MF. Understanding the Association Between Negative Symptoms and Performance on Effort-Based Decision-Making Tasks: The Importance of Defeatist Performance Beliefs. Schizophrenia Bulletin. PMID 29140501 DOI: 10.1093/Schbul/Sbx156  0.316
2017 Erickson MA, Albrecht M, Ruffle A, Fleming L, Corlett P, Gold J. No association between symptom severity and MMN impairment in schizophrenia: A meta-analytic approach. Schizophrenia Research. Cognition. 9: 13-17. PMID 28740829 DOI: 10.1016/J.Scog.2017.05.002  0.378
2017 Ermel J, Carter CS, Gold JM, MacDonald AW, Daniel Ragland J, Silverstein SM, Strauss ME, Barch DM. Self versus informant reports on the specific levels of functioning scale: Relationships to depression and cognition in schizophrenia and schizoaffective disorder. Schizophrenia Research. Cognition. 9: 1-7. PMID 28740827 DOI: 10.1016/J.Scog.2017.04.001  0.412
2017 Buchanan RW, Kelly DL, Weiner E, Gold JM, Strauss GP, Koola MM, McMahon RP, Carpenter WT. A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia. Journal of Clinical Psychopharmacology. PMID 28590362 DOI: 10.1097/Jcp.0000000000000720  0.509
2017 Ray KL, Lesh TA, Howell AM, Salo TP, Ragland JD, MacDonald AW, Gold JM, Silverstein SM, Barch DM, Carter CS. Functional network changes and cognitive control in schizophrenia. Neuroimage. Clinical. 15: 161-170. PMID 28529872 DOI: 10.1016/J.Nicl.2017.05.001  0.433
2017 Kreither J, Lopez-Calderon J, Leonard CJ, Robinson BM, Ruffle A, Hahn B, Gold JM, Luck SJ. Electrophysiological Evidence for Hyperfocusing of Spatial Attention in Schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28283557 DOI: 10.1523/Jneurosci.3221-16.2017  0.392
2017 Hahn B, Harvey AN, Gold JM, Ross TJ, Stein EA. Load-dependent hyperdeactivation of the default mode network in people with schizophrenia. Schizophrenia Research. PMID 28073606 DOI: 10.1016/J.Schres.2017.01.001  0.386
2017 Bansal S, Robinson B, Leonard C, Frankovich K, Gold J, Luck S. Spatial recall performance: Differential landmark bias in schizophrenia Journal of Vision. 17: 1332. DOI: 10.1167/17.10.1332  0.343
2017 Leonard C, Robinson B, Hahn B, Luck S, Gold J. Saccadic evidence for spatial hyperfocusing in people with schizophrenia Journal of Vision. 17: 1328. DOI: 10.1167/17.10.1328  0.326
2017 Lee HC, Chang WC, Chan SI, Waltz J, Gold J, Hui CLM, Lee EHM, Chan SKW, Chen EYH. SA27. Reinforcement Learning Performance in Early Schizophrenia Patients and Their Nonpsychotic Siblings Schizophrenia Bulletin. 43: S122-S123. DOI: 10.1093/Schbul/Sbx023.026  0.331
2017 Rubin L, Demyanovich H, Wehring H, Carter S, Pournajafi-Nazarloo H, Maki P, Feldman S, Earl A, August S, Gold J, Kelly D. M27. Peripheral Oxytocin and Vasopressin are Associated With Clinical Symptom Severity and Cognitive Functioning in Midlife Women With Chronic Schizophrenia Schizophrenia Bulletin. 43: S221-S221. DOI: 10.1093/Schbul/Sbx022.026  0.43
2017 Gold J, Stankevich B, Robinson B, Ruffle A, Geng J, Leonard C, Luck S. 206. The Impact of Reward History on Allocation of Spatial Attention in Schizophrenia Schizophrenia Bulletin. 43: S105-S106. DOI: 10.1093/Schbul/Sbx021.284  0.313
2017 Waltz J, Xu Z, Brown E, Ruiz R, Gold J. 196. Schizophrenia Patients Show Enhanced Responses to Loss Avoidance in Frontostriatal Circuits Schizophrenia Bulletin. 43: S102-S102. DOI: 10.1093/Schbul/Sbx021.274  0.32
2017 Hernaus D, Xu Z, Brown E, Ruiz R, Frank M, Gold J, Waltz J. 147. Abnormal Frontal Cortical Activity During Rapid Flexible Decision-Making in Schizophrenia: Relationships With Motivational Deficits Schizophrenia Bulletin. 43: S77-S77. DOI: 10.1093/Schbul/Sbx021.205  0.326
2017 Buchanan R, Kelly D, Strauss G, Gold J, Weiner E, McMahon R, Holden J, Granholm E. 104. Combined CBSST and Oxytocin for Social Function in People With Schizophrenia Schizophrenia Bulletin. 43: S55-S55. DOI: 10.1093/Schbul/Sbx021.142  0.306
2016 Dowd EC, Frank MJ, Collins A, Gold JM, Barch DM. Probabilistic Reinforcement Learning in Patients With Schizophrenia: Relationships to Anhedonia and Avolition. Biological Psychiatry : Cognitive Neuroscience and Neuroimaging. 1: 460-473. PMID 27833939 DOI: 10.1016/J.Bpsc.2016.05.005  0.391
2016 Sawaki R, Kreither J, Leonard CJ, Kaiser ST, Hahn B, Gold JM, Luck SJ. Hyperfocusing of Attention on Goal-Related Information in Schizophrenia: Evidence From Electrophysiology. Journal of Abnormal Psychology. PMID 27709980 DOI: 10.1037/Abn0000209  0.311
2016 Reilly JL, Hill SK, Gold JM, Keefe RS, Clementz BA, Gershon E, Keshavan MS, Pearlson G, Tamminga CA, Sweeney JA. Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. Schizophrenia Bulletin. PMID 27306316 DOI: 10.1093/Schbul/Sbw081  0.427
2016 Chang WC, Waltz JA, Gold JM, Chan TC, Chen EY. Mild Reinforcement Learning Deficits in Patients With First-Episode Psychosis. Schizophrenia Bulletin. PMID 27179125 DOI: 10.1093/Schbul/Sbw060  0.307
2016 Poppe AB, Barch DM, Carter CS, Gold JM, Ragland JD, Silverstein SM, MacDonald AW. Reduced Frontoparietal Activity in Schizophrenia Is Linked to a Specific Deficit in Goal Maintenance: A Multisite Functional Imaging Study. Schizophrenia Bulletin. PMID 27060129 DOI: 10.1093/Schbul/Sbw036  0.315
2016 Albrecht MA, Waltz JA, Cavanagh JF, Frank MJ, Gold JM. Reduction of Pavlovian Bias in Schizophrenia: Enhanced Effects in Clozapine-Administered Patients. Plos One. 11: e0152781. PMID 27044008 DOI: 10.1371/Journal.Pone.0152781  0.326
2016 Leonard C, Robinson B, Hahn B, Gold J, Luck S. Increased influence of previously attended features in people with schizophrenia Journal of Vision. 16: 424. DOI: 10.1167/16.12.424  0.354
2016 Albrecht MA, Waltz JA, Frank MJ, Gold JM. Probability and magnitude evaluation in schizophrenia Schizophrenia Research: Cognition. 5: 41-46. DOI: 10.1016/j.scog.2016.06.003  0.384
2015 McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychological Medicine. 1. PMID 26537981 DOI: 10.1017/S0033291715002433  0.645
2015 Lopez-Garcia P, Lesh TA, Salo T, Barch DM, MacDonald AW, Gold JM, Ragland JD, Strauss M, Silverstein SM, Carter CS. The neural circuitry supporting goal maintenance during cognitive control: a comparison of expectancy AX-CPT and dot probe expectancy paradigms. Cognitive, Affective & Behavioral Neuroscience. PMID 26494483 DOI: 10.3758/S13415-015-0384-1  0.342
2015 Sheffield JM, Repovs G, Harms MP, Carter CS, Gold JM, MacDonald AW, Ragland JD, Silverstein SM, Godwin D, Barch DM. Evidence for Accelerated Decline of Functional Brain Network Efficiency in Schizophrenia. Schizophrenia Bulletin. PMID 26472685 DOI: 10.1093/Schbul/Sbv148  0.352
2015 Erickson MA, Ruffle A, Gold JM. A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression. Biological Psychiatry. PMID 26444073 DOI: 10.1016/J.Biopsych.2015.08.025  0.419
2015 Waltz JA, Gold JM. Motivational Deficits in Schizophrenia and the Representation of Expected Value. Current Topics in Behavioral Neurosciences. PMID 26370946 DOI: 10.1007/7854_2015_385  0.404
2015 Keefe RS, Haig GM, Marder SR, Harvey PD, Dunayevich E, Medalia A, Davidson M, Lombardo I, Bowie CR, Buchanan RW, Bugarski-Kirola D, Carpenter WT, Csernansky JT, Dago PL, Durand DM, ... Gold JM, et al. Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia. Schizophrenia Bulletin. PMID 26362273 DOI: 10.1093/Schbul/Sbv111  0.444
2015 Horan WP, Reddy LF, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Marder SR, Wynn JK, Young JW, Green MF. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2-External Validity and Correlates. Schizophrenia Bulletin. PMID 26209546 DOI: 10.1093/Schbul/Sbv090  0.548
2015 Ragland JD, Ranganath C, Harms MP, Barch DM, Gold JM, Layher E, Lesh TA, MacDonald AW, Niendam TA, Phillips J, Silverstein SM, Yonelinas AP, Carter CS. Functional and Neuroanatomic Specificity of Episodic Memory Dysfunction in Schizophrenia: A Functional Magnetic Resonance Imaging Study of the Relational and Item-Specific Encoding Task. Jama Psychiatry. 72: 909-16. PMID 26200928 DOI: 10.1001/Jamapsychiatry.2015.0276  0.315
2015 Silverstein SM, Harms MP, Carter CS, Gold JM, Keane BP, MacDonald A, Daniel Ragland J, Barch DM. Cortical contributions to impaired contour integration in schizophrenia. Neuropsychologia. 75: 469-80. PMID 26160288 DOI: 10.1016/J.Neuropsychologia.2015.07.003  0.313
2015 Reddy LF, Horan WP, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Lyons N, Marder SR, Treadway MT, Wynn JK, Young JW, Green MF. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1-Psychometric Characteristics of 5 Paradigms. Schizophrenia Bulletin. PMID 26142081 DOI: 10.1093/Schbul/Sbv089  0.626
2015 Green MF, Horan WP, Barch DM, Gold JM. Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia. Schizophrenia Bulletin. PMID 26089350 DOI: 10.1093/Schbul/Sbv071  0.581
2015 Kelly DL, Sullivan KM, McEvoy JP, McMahon RP, Wehring HJ, Gold JM, Liu F, Warfel D, Vyas G, Richardson CM, Fischer BA, Keller WR, Koola MM, Feldman SM, Russ JC, et al. Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms. Journal of Clinical Psychopharmacology. 35: 374-81. PMID 26082974 DOI: 10.1097/Jcp.0000000000000345  0.414
2015 Gold JM, Waltz JA, Frank MJ. Effort Cost Computation in Schizophrenia: A Commentary on the Recent Literature. Biological Psychiatry. PMID 26049208 DOI: 10.1016/J.Biopsych.2015.05.005  0.39
2015 Culbreth AJ, Gold JM, Cools R, Barch DM. Impaired Activation in Cognitive Control Regions Predicts Reversal Learning in Schizophrenia. Schizophrenia Bulletin. PMID 26049083 DOI: 10.1093/Schbul/Sbv075  0.351
2015 Kristian Hill S, Buchholz A, Amsbaugh H, Reilly JL, Rubin LH, Gold JM, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment. Schizophrenia Research. 166: 310-5. PMID 26008884 DOI: 10.1016/J.Schres.2015.05.018  0.344
2015 Sheffield JM, Repovs G, Harms MP, Carter CS, Gold JM, MacDonald Iii AW, Daniel Ragland J, Silverstein SM, Godwin D, Barch DM. Fronto-parietal and cingulo-opercular network integrity and cognition in health and schizophrenia. Neuropsychologia. 73: 82-93. PMID 25979608 DOI: 10.1016/J.Neuropsychologia.2015.05.006  0.396
2015 Brown EC, Hack SM, Gold JM, Carpenter WT, Fischer BA, Prentice KP, Waltz JA. Integrating frequency and magnitude information in decision-making in schizophrenia: An account of patient performance on the Iowa Gambling Task. Journal of Psychiatric Research. 66: 16-23. PMID 25959618 DOI: 10.1016/J.Jpsychires.2015.04.007  0.36
2015 McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychological Medicine. 1-10. PMID 25916421 DOI: 10.1017/S0033291715000641  0.66
2015 Morra LF, Gold JM, Sullivan SK, Strauss GP. Predictors of neuropsychological effort test performance in schizophrenia. Schizophrenia Research. 162: 205-10. PMID 25583248 DOI: 10.1016/J.Schres.2014.12.033  0.474
2015 Strauss GP, Keller WR, Koenig JI, Gold JM, Ossenfort KL, Buchanan RW. Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia. Schizophrenia Research. 162: 57-61. PMID 25583247 DOI: 10.1016/J.Schres.2014.12.023  0.367
2015 Erickson MA, Hahn B, Leonard CJ, Robinson B, Gray B, Luck SJ, Gold J. Impaired working memory capacity is not caused by failures of selective attention in schizophrenia. Schizophrenia Bulletin. 41: 366-73. PMID 25031223 DOI: 10.1093/Schbul/Sbu101  0.367
2015 Strauss GP, Morra LF, Sullivan SK, Gold JM. The role of low cognitive effort and negative symptoms in neuropsychological impairment in schizophrenia. Neuropsychology. 29: 282-91. PMID 25000322 DOI: 10.1037/Neu0000113  0.454
2015 Gold JM, Kool W, Botvinick MM, Hubzin L, August S, Waltz JA. Cognitive effort avoidance and detection in people with schizophrenia. Cognitive, Affective & Behavioral Neuroscience. 15: 145-54. PMID 24957405 DOI: 10.3758/S13415-014-0308-5  0.463
2015 Slepian ML, Ferber SN, Gold JM, Rutchick AM. The Cognitive Consequences of Formal Clothing Social Psychological and Personality Science. 6: 661-668. DOI: 10.1177/1948550615579462  0.301
2015 Kelly D, Buchanan R, McMahon R, Gold J, Feldman S, August S, Sullivan K, Osing J, Carpenter W. S.13.04 Effects of intranasal oxytocin or galantamine for primary enduring negative symptoms and cognitive impairments in people with schizophrenia European Neuropsychopharmacology. 25: S131. DOI: 10.1016/S0924-977X(15)30071-7  0.489
2015 Silverstein SM, Harms MP, Carter CS, Gold JM, Keane BP, MacDonald A, Daniel Ragland J, Barch DM. Cortical contributions to impaired contour integration in schizophrenia Neuropsychologia. 75: 469-480. DOI: 10.1016/j.neuropsychologia.2015.07.003  0.386
2014 Erickson M, Hahn B, Leonard C, Robinson B, Luck S, Gold J. Enhanced vulnerability to distraction does not account for working memory capacity reduction in people with schizophrenia. Schizophrenia Research. Cognition. 1: 149-154. PMID 25705590 DOI: 10.1016/J.Scog.2014.09.001  0.382
2014 Wonodi I, McMahon RP, Krishna N, Mitchell BD, Liu J, Glassman M, Hong LE, Gold JM. Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia. Schizophrenia Research. 160: 80-7. PMID 25464917 DOI: 10.1016/J.Schres.2014.10.026  0.488
2014 Collins AG, Brown JK, Gold JM, Waltz JA, Frank MJ. Working memory contributions to reinforcement learning impairments in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 13747-56. PMID 25297101 DOI: 10.1523/Jneurosci.0989-14.2014  0.32
2014 Sullivan S, Strauss G, Ossenfort K, Katz A, Gold J. C-83The Role of IQ in Effort Test Performance in Schizophrenia. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 604. PMID 25176926 DOI: 10.1093/Arclin/Acu038.264  0.353
2014 Morra L, Gold J, Ossenfort K, Strauss G. C-78Predicting Insufficient Effort in Schizophrenia using the Repeated Battery for the Assessment of Neuropsychological Status Effort Index. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 602-3. PMID 25176921 DOI: 10.1093/Arclin/Acu038.259  0.361
2014 Ossenfort K, Frost K, Katz A, Chiu I, Strauss G, Gold J. C-18Negative Symptoms Predict Neuropsychological Impairment in Schizophrenia. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 579. PMID 25176861 DOI: 10.1093/Arclin/Acu038.199  0.376
2014 Frost K, Keller W, Buchanan R, Gold J, Koenig J, Ossenfort K, Katz A, Strauss G. C-14Plasma Oxytocin Levels are Associated with Impaired Social Cognition and Neurocognition in Schizophrenia. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 577-8. PMID 25176857 DOI: 10.1093/Arclin/Acu038.195  0.41
2014 Katz A, Chui I, Powell M, Varuzza G, Gold J, Strauss G. C-08Impaired Cognitive Control and Goal Maintenance in Schizophrenia. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 575. PMID 25176851 DOI: 10.1093/Arclin/Acu038.189  0.482
2014 Gray BE, McMahon RP, Green MF, Seidman LJ, Mesholam-Gately RI, Kern RS, Nuechterlein KH, Keefe RS, Gold JM. Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. Schizophrenia Research. 159: 182-7. PMID 25156338 DOI: 10.1016/J.Schres.2014.07.032  0.537
2014 Kiwanuka JN, Strauss GP, McMahon RP, Gold JM. Psychological predictors of functional outcome in people with schizophrenia. Schizophrenia Research. 157: 299-304. PMID 24878429 DOI: 10.1016/J.Schres.2014.04.030  0.365
2014 Gray BE, Hahn B, Robinson B, Harvey A, Leonard CJ, Luck SJ, Gold JM. Relationships between divided attention and working memory impairment in people with schizophrenia. Schizophrenia Bulletin. 40: 1462-71. PMID 24748559 DOI: 10.1093/Schbul/Sbu015  0.401
2014 Leonard CJ, Robinson BM, Hahn B, Gold JM, Luck SJ. Enhanced distraction by magnocellular salience signals in schizophrenia. Neuropsychologia. 56: 359-66. PMID 24561035 DOI: 10.1016/J.Neuropsychologia.2014.02.011  0.411
2014 Sheffield JM, Gold JM, Strauss ME, Carter CS, MacDonald AW, Ragland JD, Silverstein SM, Barch DM. Common and specific cognitive deficits in schizophrenia: relationships to function. Cognitive, Affective & Behavioral Neuroscience. 14: 161-74. PMID 24037621 DOI: 10.3758/S13415-013-0211-5  0.447
2014 Strauss ME, McLouth CJ, Barch DM, Carter CS, Gold JM, Luck SJ, MacDonald AW, Ragland JD, Ranganath C, Keane BP, Silverstein SM. Temporal stability and moderating effects of age and sex on CNTRaCS task performance. Schizophrenia Bulletin. 40: 835-44. PMID 23817024 DOI: 10.1093/Schbul/Sbt089  0.391
2014 Chan TCW, Chang W, Gold J, Waltz J, Hui C, Chan K, Lee H, Chen E. Poster #M84 REWARD LEARNING IMPAIRMENT IN PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA-SPECTRUM DISORDER Schizophrenia Research. 153: S220. DOI: 10.1016/S0920-9964(14)70634-6  0.369
2013 Leonard CJ, Robinson BM, Kaiser ST, Hahn B, McClenon C, Harvey AN, Luck SJ, Gold JM. Testing sensory and cognitive explanations of the antisaccade deficit in schizophrenia. Journal of Abnormal Psychology. 122: 1111-20. PMID 24364614 DOI: 10.1037/A0034956  0.393
2013 Hill SK, Reilly JL, Keefe RS, Gold JM, Bishop JR, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. The American Journal of Psychiatry. 170: 1275-84. PMID 23771174 DOI: 10.1176/Appi.Ajp.2013.12101298  0.442
2013 Brown JK, Waltz JA, Strauss GP, McMahon RP, Frank MJ, Gold JM. Hypothetical decision making in schizophrenia: the role of expected value computation and "irrational" biases. Psychiatry Research. 209: 142-9. PMID 23664664 DOI: 10.1016/J.Psychres.2013.02.034  0.377
2013 Gray BE, McMahon RP, Gold JM. General intellectual ability does not explain the general deficit in schizophrenia. Schizophrenia Research. 147: 315-9. PMID 23664590 DOI: 10.1016/J.Schres.2013.04.016  0.523
2013 Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biological Psychiatry. 74: 436-43. PMID 23660272 DOI: 10.1016/J.Biopsych.2013.03.017  0.334
2013 Johnson MK, McMahon RP, Robinson BM, Harvey AN, Hahn B, Leonard CJ, Luck SJ, Gold JM. The relationship between working memory capacity and broad measures of cognitive ability in healthy adults and people with schizophrenia. Neuropsychology. 27: 220-9. PMID 23527650 DOI: 10.1037/A0032060  0.45
2013 Owoso A, Carter CS, Gold JM, MacDonald AW, Ragland JD, Silverstein SM, Strauss ME, Barch DM. Cognition in schizophrenia and schizo-affective disorder: impairments that are more similar than different. Psychological Medicine. 43: 2535-45. PMID 23522057 DOI: 10.1017/S0033291713000536  0.522
2013 Waltz JA, Kasanova Z, Ross TJ, Salmeron BJ, McMahon RP, Gold JM, Stein EA. The roles of reward, default, and executive control networks in set-shifting impairments in schizophrenia. Plos One. 8: e57257. PMID 23468948 DOI: 10.1371/Journal.Pone.0057257  0.339
2013 Gold JM, Dickinson D. "Generalized cognitive deficit" in schizophrenia: overused or underappreciated? Schizophrenia Bulletin. 39: 263-5. PMID 23211397 DOI: 10.1093/Schbul/Sbs143  0.502
2013 Hahn B, Gold JM, Buchanan RW. The potential of nicotinic enhancement of cognitive remediation training in schizophrenia. Neuropharmacology. 64: 185-90. PMID 22705396 DOI: 10.1016/J.Neuropharm.2012.05.050  0.452
2012 Knowles EE, Weiser M, David AS, Dickinson D, Glahn D, Gold J, Davidson M, Reichenberg A. Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia. Schizophrenia Research. 142: 129-36. PMID 23084540 DOI: 10.1016/J.Schres.2012.08.020  0.466
2012 Strauss GP, Lee BG, Waltz JA, Robinson BM, Brown JK, Gold JM. Cognition-emotion interactions are modulated by working memory capacity in individuals with schizophrenia. Schizophrenia Research. 141: 257-61. PMID 22968207 DOI: 10.1016/J.Schres.2012.08.010  0.34
2012 Keane BP, Silverstein SM, Barch DM, Carter CS, Gold JM, Kovács I, MacDonald AW, Ragland JD, Strauss ME. The spatial range of contour integration deficits in schizophrenia. Experimental Brain Research. 220: 251-9. PMID 22710617 DOI: 10.1007/S00221-012-3134-4  0.34
2012 Hahn B, Robinson BM, Kaiser ST, Matveeva TM, Harvey AN, Luck SJ, Gold JM. Kraepelin and Bleuler had it right: people with schizophrenia have deficits sustaining attention over time. Journal of Abnormal Psychology. 121: 641-8. PMID 22686867 DOI: 10.1037/A0028492  0.331
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation. Schizophrenia Research. 140: 1-8. PMID 22503642 DOI: 10.1016/J.Schres.2012.03.025  0.599
2012 Harvey PD, Heaton RK, Carpenter WT, Green MF, Gold JM, Schoenbaum M. Diagnosis of schizophrenia: consistency across information sources and stability of the condition. Schizophrenia Research. 140: 9-14. PMID 22503641 DOI: 10.1016/J.Schres.2012.03.026  0.569
2012 Gold J. Cognitive neuroscience test reliability and clinical applications for schizophrenia. Schizophrenia Bulletin. 38: 103. PMID 22199091 DOI: 10.1093/Schbul/Sbr173  0.523
2012 Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, et al. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophrenia Research. 136: 25-31. PMID 22169248 DOI: 10.1016/J.Schres.2011.11.001  0.646
2012 Boggs DL, Kelly DL, McMahon RP, Gold JM, Gorelick DA, Linthicum J, Conley RR, Liu F, Waltz J, Huestis MA, Buchanan RW. Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial. Schizophrenia Research. 134: 207-10. PMID 22137462 DOI: 10.1016/J.Schres.2011.11.009  0.412
2012 Ragland JD, Ranganath C, Barch DM, Gold JM, Haley B, MacDonald AW, Silverstein SM, Strauss ME, Yonelinas AP, Carter CS. Relational and Item-Specific Encoding (RISE): task development and psychometric characteristics. Schizophrenia Bulletin. 38: 114-24. PMID 22124089 DOI: 10.1093/Schbul/Sbr146  0.356
2012 Barch DM, Carter CS, Dakin SC, Gold J, Luck SJ, Macdonald A, Ragland JD, Silverstein S, Strauss ME. The clinical translation of a measure of gain control: the contrast-contrast effect task. Schizophrenia Bulletin. 38: 135-43. PMID 22101963 DOI: 10.1093/Schbul/Sbr154  0.386
2012 Gold JM, Barch DM, Carter CS, Dakin S, Luck SJ, MacDonald AW, Ragland JD, Ranganath C, Kovacs I, Silverstein SM, Strauss M. Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium. Schizophrenia Bulletin. 38: 144-52. PMID 22101961 DOI: 10.1093/Schbul/Sbr142  0.448
2012 August SM, Kiwanuka JN, McMahon RP, Gold JM. The MATRICS Consensus Cognitive Battery (MCCB): clinical and cognitive correlates. Schizophrenia Research. 134: 76-82. PMID 22093182 DOI: 10.1016/J.Schres.2011.10.015  0.515
2012 Silverstein SM, Keane BP, Barch DM, Carter CS, Gold JM, Kovács I, MacDonald A, Ragland JD, Strauss ME. Optimization and validation of a visual integration test for schizophrenia research. Schizophrenia Bulletin. 38: 125-34. PMID 22021658 DOI: 10.1093/Schbul/Sbr141  0.392
2012 Strauss GP, Catalano LT, Gold JM. Poster #68 A NEW PERSPECTIVE ON ANHEDONIA IN SCHIZOPHRENIA Schizophrenia Research. 136: S305. DOI: 10.1016/S0920-9964(12)70901-5  0.383
2012 Strauss GP, Gold JM, Cohen AS. Response to Gooding and Plfum, "The nature of diminished pleasure in individuals at risk for or affected by schizophrenia". Anticipatory and consummatory pleasure deficits across the schizophrenia spectrum Psychiatry Research. 198: 174-175. DOI: 10.1016/J.Psychres.2012.06.040  0.397
2011 Morris SE, Holroyd CB, Mann-Wrobel MC, Gold JM. Dissociation of response and feedback negativity in schizophrenia: electrophysiological and computational evidence for a deficit in the representation of value. Frontiers in Human Neuroscience. 5: 123. PMID 22065618 DOI: 10.3389/Fnhum.2011.00123  0.327
2011 Reise SP, Ventura J, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder R. Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia. Psychological Assessment. 23: 245-61. PMID 21381848 DOI: 10.1037/A0021501  0.623
2011 Strauss GP, Wilbur RC, Warren KR, August SM, Gold JM. Anticipatory vs. consummatory pleasure: what is the nature of hedonic deficits in schizophrenia? Psychiatry Research. 187: 36-41. PMID 21295860 DOI: 10.1016/J.Psychres.2011.01.012  0.391
2011 Heerey EA, Matveeva TM, Gold JM. Imagining the future: degraded representations of future rewards and events in schizophrenia. Journal of Abnormal Psychology. 120: 483-9. PMID 21171727 DOI: 10.1037/A0021810  0.468
2011 Strauss GP, Frank MJ, Waltz JA, Kasanova Z, Herbener ES, Gold JM. Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia. Biological Psychiatry. 69: 424-31. PMID 21168124 DOI: 10.1016/J.Biopsych.2010.10.015  0.363
2011 Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Baade LE, Keefe RS, Mesholam-Gately RI, Seidman LJ, Lee C, Sugar CA, Marder SR. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophrenia Research. 126: 124-31. PMID 21159492 DOI: 10.1016/J.Schres.2010.11.008  0.648
2011 Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, Gold JM, Green MF, Jarskog LF, Javitt DC, Kimhy D, Kraus MS, McEvoy JP, Mesholam-Gately RI, Seidman LJ, et al. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biological Psychiatry. 69: 442-9. PMID 21145041 DOI: 10.1016/J.Biopsych.2010.09.052  0.676
2011 Wisner KM, ElvevÃ¥g B, Gold JM, Weinberger DR, Dickinson D. A closer look at siblings of patients with schizophrenia: the association of depression history and sex with cognitive phenotypes. Schizophrenia Research. 126: 164-73. PMID 21030214 DOI: 10.1016/J.Schres.2010.09.011  0.39
2011 Dickinson D, Goldberg TE, Gold JM, Elvevåg B, Weinberger DR. Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls. Schizophrenia Bulletin. 37: 1157-67. PMID 20351040 DOI: 10.1093/Schbul/Sbq018  0.453
2011 Hahn B, Kappenman ES, Robinson BM, Fuller RL, Luck SJ, Gold JM. Iconic decay in schizophrenia. Schizophrenia Bulletin. 37: 950-7. PMID 20053864 DOI: 10.1093/Schbul/Sbp164  0.318
2011 Gold JM. Is cognitive impairment in schizophrenia ready for diagnostic prime time? World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 7: 32-3. PMID 18458780 DOI: 10.1002/J.2051-5545.2008.Tb00145.X  0.545
2011 Goldberg TE, David A, Gold JM. Neurocognitive Impairments in Schizophrenia: Their Character and Role in Symptom Formation Schizophrenia: Third Edition. 142-162. DOI: 10.1002/9781444327298.ch8  0.395
2010 Hahn B, Robinson BM, Kaiser ST, Harvey AN, Beck VM, Leonard CJ, Kappenman ES, Luck SJ, Gold JM. Failure of schizophrenia patients to overcome salient distractors during working memory encoding. Biological Psychiatry. 68: 603-9. PMID 20570242 DOI: 10.1016/J.Biopsych.2010.04.014  0.316
2010 Ventura J, Reise SP, Keefe RS, Baade LE, Gold JM, Green MF, Kern RS, Mesholam-Gately R, Nuechterlein KH, Seidman LJ, Bilder RM. The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. Schizophrenia Research. 121: 24-31. PMID 20542412 DOI: 10.1016/J.Schres.2010.04.016  0.629
2010 Gold JM, Hahn B, Zhang WW, Robinson BM, Kappenman ES, Beck VM, Luck SJ. Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. Archives of General Psychiatry. 67: 570-7. PMID 20530006 DOI: 10.1001/Archgenpsychiatry.2010.65  0.401
2010 Dickinson D, Tenhula W, Morris S, Brown C, Peer J, Spencer K, Li L, Gold JM, Bellack AS. A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia. The American Journal of Psychiatry. 167: 170-80. PMID 20008941 DOI: 10.1176/Appi.Ajp.2009.09020264  0.496
2010 Kern RS, Gold JM, Dickinson D, Green MF, Nuechterlein KH, Keefe RS, Marder SR, Sugar CA. COGNITIVE DYSFUNCTION AND COMMUNITY FUNCTIONING IN SCHIZOPHRENIA: RESULTS FROM THE MATRICS PSYCHOMETRIC AND STANDARDIZATION STUDY (PASS) Schizophrenia Research. 117: 323-324. DOI: 10.1016/J.Schres.2010.02.551  0.483
2009 Gold JM, Hahn B, Strauss GP, Waltz JA. Turning it upside down: areas of preserved cognitive function in schizophrenia. Neuropsychology Review. 19: 294-311. PMID 19452280 DOI: 10.1007/S11065-009-9098-X  0.537
2009 Luck SJ, Kappenman ES, Fuller RL, Robinson B, Summerfelt A, Gold JM. Impaired response selection in schizophrenia: evidence from the P3 wave and the lateralized readiness potential. Psychophysiology. 46: 776-86. PMID 19386044 DOI: 10.1111/J.1469-8986.2009.00817.X  0.322
2009 Kelly DL, Buchanan RW, Boggs DL, McMahon RP, Dickinson D, Nelson M, Gold JM, Ball MP, Feldman S, Liu F, Conley RR. A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia. The Journal of Clinical Psychiatry. 70: 518-25. PMID 19358788 DOI: 10.4088/Jcp.08M04358  0.493
2009 Fuller RL, Luck SJ, Braun EL, Robinson BM, McMahon RP, Gold JM. Impaired visual working memory consolidation in schizophrenia. Neuropsychology. 23: 71-80. PMID 19210034 DOI: 10.1037/A0013854  0.352
2008 Skelley SL, Goldberg TE, Egan MF, Weinberger DR, Gold JM. Verbal and visual memory: characterizing the clinical and intermediate phenotype in schizophrenia. Schizophrenia Research. 105: 78-85. PMID 18617370 DOI: 10.1016/J.Schres.2008.05.027  0.371
2008 Ceaser AE, Goldberg TE, Egan MF, McMahon RP, Weinberger DR, Gold JM. Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype? Biological Psychiatry. 64: 782-8. PMID 18597738 DOI: 10.1016/J.Biopsych.2008.05.009  0.428
2008 Keefe RSE, Harvey PD, Goldberg TE, Gold JM, Walker TM, Kennel C, Hawkins K. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS) Schizophrenia Research. 102: 108-115. PMID 18495435 DOI: 10.1016/J.Schres.2008.03.024  0.535
2008 Luck SJ, Gold JM. The translation of cognitive paradigms for patient research. Schizophrenia Bulletin. 34: 629-44. PMID 18487226 DOI: 10.1093/Schbul/Sbn036  0.365
2008 Dickinson D, Ragland JD, Gold JM, Gur RC. General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biological Psychiatry. 64: 823-7. PMID 18472089 DOI: 10.1016/J.Biopsych.2008.04.005  0.5
2008 Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, Allensworth D, Guzman-Bonilla A, Clement B, Ball MP, Kutnick J, Pender V, Martin LF, Stevens KE, Wagner BD, et al. Initial phase 2 trial of a nicotinic agonist in schizophrenia. The American Journal of Psychiatry. 165: 1040-7. PMID 18381905 DOI: 10.1176/Appi.Ajp.2008.07071135  0.413
2008 Heerey EA, Bell-Warren KR, Gold JM. Decision-making impairments in the context of intact reward sensitivity in schizophrenia. Biological Psychiatry. 64: 62-9. PMID 18377874 DOI: 10.1016/J.Biopsych.2008.02.015  0.362
2008 Luck SJ, Gold JM. The construct of attention in schizophrenia. Biological Psychiatry. 64: 34-9. PMID 18374901 DOI: 10.1016/J.Biopsych.2008.02.014  0.372
2008 Dickinson D, Gold JM, Dickerson FB, Medoff D, Dixon LB. Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes. Psychosomatics. 49: 123-31. PMID 18354065 DOI: 10.1176/Appi.Psy.49.2.123  0.436
2008 Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. The American Journal of Psychiatry. 165: 203-13. PMID 18172019 DOI: 10.1176/Appi.Ajp.2007.07010042  0.661
2008 Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. The American Journal of Psychiatry. 165: 214-20. PMID 18172018 DOI: 10.1176/Appi.Ajp.2007.07010043  0.607
2008 Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. The American Journal of Psychiatry. 165: 221-8. PMID 18172017 DOI: 10.1176/Appi.Ajp.2007.07010089  0.598
2008 Buchanan RW, Conley RR, Dickinson D, Ball MP, Feldman S, Gold JM, McMahon RP. Galantamine for the treatment of cognitive impairments in people with schizophrenia. The American Journal of Psychiatry. 165: 82-9. PMID 17986678 DOI: 10.1176/Appi.Ajp.2007.07050724  0.411
2008 Prentice KJ, Gold JM, Buchanan RW. The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials. Schizophrenia Research. 106: 81-7. PMID 17933496 DOI: 10.1016/J.Schres.2007.07.015  0.416
2008 Morris SE, Heerey EA, Gold JM, Holroyd CB. Learning-related changes in brain activity following errors and performance feedback in schizophrenia. Schizophrenia Research. 99: 274-85. PMID 17889510 DOI: 10.1016/J.Schres.2007.08.027  0.326
2008 Dickinson D, Gold JM. Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia. Schizophrenia Bulletin. 34: 423-34. PMID 17702991 DOI: 10.1093/Schbul/Sbm092  0.51
2007 Robles O, Blaxton T, Adami H, Arango C, Thaker G, Gold J. Nonverbal delayed recognition in the relatives of schizophrenia patients with or without schizophrenia spectrum. Biological Psychiatry. 63: 498-504. PMID 17916332 DOI: 10.1016/J.Biopsych.2007.05.016  0.46
2007 Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP, Heresco-Levy U, Carpenter WT. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. The American Journal of Psychiatry. 164: 1593-602. PMID 17898352 DOI: 10.1176/Appi.Ajp.2007.06081358  0.449
2007 Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry. 64: 633-47. PMID 17548746 DOI: 10.1001/Archpsyc.64.6.633  0.543
2007 Heerey EA, Gold JM. Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. Journal of Abnormal Psychology. 116: 268-78. PMID 17516760 DOI: 10.1037/0021-843X.116.2.268  0.346
2007 Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry. 64: 532-42. PMID 17485605 DOI: 10.1001/Archpsyc.64.5.532  0.446
2007 Waltz JA, Gold JM. Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophrenia Research. 93: 296-303. PMID 17482797 DOI: 10.1016/J.Schres.2007.03.010  0.349
2007 Heerey EA, Robinson BM, McMahon RP, Gold JM. Delay discounting in schizophrenia. Cognitive Neuropsychiatry. 12: 213-21. PMID 17453902 DOI: 10.1080/13546800601005900  0.404
2007 Dickinson D, Bellack AS, Gold JM. Social/communication skills, cognition, and vocational functioning in schizophrenia. Schizophrenia Bulletin. 33: 1213-20. PMID 17164469 DOI: 10.1093/Schbul/Sbl067  0.409
2007 Cohen AS, Saperstein AM, Gold JM, Kirkpatrick B, Carpenter WT, Buchanan RW. Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date. Schizophrenia Bulletin. 33: 1201-12. PMID 17159230 DOI: 10.1093/Schbul/Sbl066  0.444
2006 Avila MT, Robles O, Hong LE, Blaxton TA, Myers CS, Wonodi I, Gold J, Thaker GK. Deficits on the Continuous Performance Test within the schizophrenia spectrum and the mediating effects of family history of schizophrenia. Journal of Abnormal Psychology. 115: 771-8. PMID 17100534 DOI: 10.1037/0021-843X.115.4.771  0.447
2006 Fuller RL, Luck SJ, Braun EL, Robinson BM, McMahon RP, Gold JM. Impaired control of visual attention in schizophrenia. Journal of Abnormal Psychology. 115: 266-75. PMID 16737391 DOI: 10.1037/0021-843X.115.2.266  0.318
2006 Shepard PD, Holcomb HH, Gold JM. Schizophrenia in translation: the presence of absence: habenular regulation of dopamine neurons and the encoding of negative outcomes. Schizophrenia Bulletin. 32: 417-21. PMID 16717257 DOI: 10.1093/Schbul/Sbj083  0.336
2006 Luck SJ, Fuller RL, Braun EL, Robinson B, Summerfelt A, Gold JM. The speed of visual attention in schizophrenia: electrophysiological and behavioral evidence. Schizophrenia Research. 85: 174-95. PMID 16713184 DOI: 10.1016/J.Schres.2006.03.040  0.348
2006 Saperstein AM, Fuller RL, Avila MT, Adami H, McMahon RP, Thaker GK, Gold JM. Spatial working memory as a cognitive endophenotype of schizophrenia: assessing risk for pathophysiological dysfunction. Schizophrenia Bulletin. 32: 498-506. PMID 16687386 DOI: 10.1093/Schbul/Sbj072  0.441
2006 Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2033-46. PMID 16641947 DOI: 10.1038/Sj.Npp.1301072  0.628
2006 Velligan DI, Kern RS, Gold JM. Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies Schizophrenia Bulletin. 32: 474-485. PMID 16641424 DOI: 10.1093/Schbul/Sbj071  0.498
2006 Dickinson D, Ragland JD, Calkins ME, Gold JM, Gur RC. A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis. Schizophrenia Research. 85: 20-9. PMID 16616831 DOI: 10.1016/J.Schres.2006.03.003  0.489
2006 Potter D, Summerfelt A, Gold J, Buchanan RW. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophrenia Bulletin. 32: 692-700. PMID 16469942 DOI: 10.1093/Schbul/Sbj050  0.309
2005 Wilk CM, Gold JM, McMahon RP, Humber K, Iannone VN, Buchanan RW. No, it is not possible to be schizophrenic yet neuropsychologically normal Neuropsychology. 19: 778-786. PMID 16351353 DOI: 10.1037/0894-4105.19.6.778  0.464
2005 Fuller RL, Luck SJ, McMahon RP, Gold JM. Working memory consolidation is abnormally slow in schizophrenia. Journal of Abnormal Psychology. 114: 279-90. PMID 15869358 DOI: 10.1037/0021-843X.114.2.279  0.359
2005 Prentice KJ, Gold JM, Carpenter WT. Optimistic bias in the perception of personal risk: patterns in schizophrenia. The American Journal of Psychiatry. 162: 507-12. PMID 15741467 DOI: 10.1176/Appi.Ajp.162.3.507  0.328
2005 Buchanan RW, Ball MP, Weiner E, Kirkpatrick B, Gold JM, McMahon RP, Carpenter WT. Olanzapine treatment of residual positive and negative symptoms. The American Journal of Psychiatry. 162: 124-9. PMID 15625210 DOI: 10.1016/S0920-9964(03)80437-1  0.362
2005 Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophrenia Research. 72: 21-8. PMID 15531404 DOI: 10.1016/J.Schres.2004.09.008  0.493
2004 Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophrenia Research. 72: 29-39. PMID 15531405 DOI: 10.1016/J.Schres.2004.09.007  0.668
2004 Gold JM, Poet MS, Wilk CM, Buchanan RW. The family pictures test as a measure of impaired feature binding in schizophrenia. Journal of Clinical and Experimental Neuropsychology. 26: 511-20. PMID 15512938 DOI: 10.1080/13803390490496669  0.335
2004 Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry. 56: 301-7. PMID 15336511 DOI: 10.1016/J.Biopsych.2004.06.023  0.659
2004 Wilk CM, Gold JM, Humber K, Dickerson F, Fenton WS, Buchanan RW. Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status. Schizophrenia Research. 70: 175-86. PMID 15329294 DOI: 10.1016/J.Schres.2003.10.009  0.476
2004 Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research. 68: 283-97. PMID 15099610 DOI: 10.1016/J.Schres.2003.09.011  0.526
2004 Dickinson D, Iannone VN, Wilk CM, Gold JM. General and specific cognitive deficits in schizophrenia. Biological Psychiatry. 55: 826-33. PMID 15050864 DOI: 10.1016/J.Biopsych.2003.12.010  0.542
2003 Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophrenia Bulletin. 29: 45-55. PMID 12908660 DOI: 10.1093/Oxfordjournals.Schbul.A006990  0.594
2003 Gold JM, Wilk CM, McMahon RP, Buchanan RW, Luck SJ. Working memory for visual features and conjunctions in schizophrenia. Journal of Abnormal Psychology. 112: 61-71. PMID 12653414 DOI: 10.1037/0021-843X.112.1.61  0.346
2003 Buchanan RW, Summerfelt A, Tek C, Gold J. An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia. Schizophrenia Research. 59: 29-33. PMID 12413639 DOI: 10.1016/S0920-9964(01)00387-5  0.465
2003 Humber K, Wilk C, Dickerson F, Buchanan R, Gold J. Neuropsychological screening in schizophrenia: Psychometric properties of the repeatable battery for the assessment of neuropsychological status (RBANS) Schizophrenia Research. 60: 171. DOI: 10.1016/S0920-9964(03)81042-3  0.382
2003 Gold J, Wilk C, Humber K, Iannone V, Thaker G, McMahon R, Buchanan R. Cognitive markers of illness and disability in schizophrenia Schizophrenia Research. 60: 135-136. DOI: 10.1016/S0920-9964(03)80930-1  0.506
2003 Dickinson D, Iannone V, Wilk C, Gold J. General and specific cognitive deficits in schizophrenia Schizophrenia Research. 60: 131. DOI: 10.1016/S0920-9964(03)80916-7  0.515
2003 Wonodi I, Stine C, Mitchell B, Gold J, Buchanan R, Thaker G. Prefrontal cortical dysfunction and genetic polymorphisms of the COMT gene in subjects with schizophrenia: A genetic study of a schizophrenia endophenotype Schizophrenia Research. 60: 91-92. DOI: 10.1016/S0920-9964(03)80659-X  0.322
2003 Prentice K, Bellack A, Gold J, Carpenter W. Improving decisional capacity for informed consent in schizophrenia Schizophrenia Research. 60: 327-328. DOI: 10.1016/S0920-9964(03)80298-0  0.359
2003 Morris S, Dickinson D, Bellack A, Tenhula W, Gold J. The development of a computer-based cognitive remediation program for schizophrenia Schizophrenia Research. 60: 326. DOI: 10.1016/S0920-9964(03)80293-1  0.456
2002 Gold JM, Thaker GK. Current progress in schizophrenia research: cognitive phenotypes of schizophrenia: attention. The Journal of Nervous and Mental Disease. 190: 638-9. PMID 12357099 DOI: 10.1097/00005053-200209000-00010  0.48
2002 Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF. Cognitive correlates of job tenure among patients with severe mental illness. The American Journal of Psychiatry. 159: 1395-402. PMID 12153834 DOI: 10.1176/Appi.Ajp.159.8.1395  0.451
2002 Carpenter WT, Gold JM. Another view of therapy for cognition in schizophrenia. Biological Psychiatry. 51: 969-71. PMID 12062880 DOI: 10.1016/S0006-3223(02)01399-9  0.468
2002 Wilk CM, Gold JM, Bartko JJ, Dickerson F, Fenton WS, Knable M, Randolph C, Buchanan RW. Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. The American Journal of Psychiatry. 159: 838-44. PMID 11986139 DOI: 10.1176/Appi.Ajp.159.5.838  0.47
2002 Tek C, Gold J, Blaxton T, Wilk C, McMahon RP, Buchanan RW. Visual perceptual and working memory impairments in schizophrenia. Archives of General Psychiatry. 59: 146-53. PMID 11825136 DOI: 10.1001/Archpsyc.59.2.146  0.327
2001 Thaker G, Adami H, Gold J. Functional deterioration in individuals with schizophrenia spectrum personality symptoms. Journal of Personality Disorders. 15: 229-34. PMID 11406994 DOI: 10.1521/Pedi.15.3.229.19207  0.304
2001 Blyler CR, Gold JM, Iannone VN, Buchanan RW. Short form of the WAIS-III for use with patients with schizophrenia. Schizophrenia Research. 46: 209-15. PMID 11120433 DOI: 10.1016/S0920-9964(00)00017-7  0.409
2001 Bellack AS, Buchanan RW, Gold JM. The American Psychiatric Association practice guidelines for schizophrenia: Scientific base and relevance for behavior therapy Behavior Therapy. 32: 283-308. DOI: 10.1016/S0005-7894(01)80006-X  0.337
2000 Weickert TW, Goldberg TE, Gold JM, Bigelow LB, Egan MF, Weinberger DR. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Archives of General Psychiatry. 57: 907-13. PMID 10986554 DOI: 10.1001/Archpsyc.57.9.907  0.498
2000 Carpenter WT, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS. Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry. 57: 533-8. PMID 10839330 DOI: 10.1001/Archpsyc.57.6.533  0.412
2000 Gold JM, Rehkemper G, Binks SW, Carpenter CJ, Fleming K, Goldberg TE, Weinberger DR. Learning and forgetting in schizophrenia. Journal of Abnormal Psychology. 109: 534-538. DOI: 10.1037/0021-843X.109.3.534  0.426
1999 Hobart MP, Goldberg R, Bartko JJ, Gold JM. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons. The American Journal of Psychiatry. 156: 1951-7. PMID 10588410 DOI: 10.1176/Ajp.156.12.1951  0.439
1999 Gold JM, Queern C, Iannone VN, Buchanan RW. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity. The American Journal of Psychiatry. 156: 1944-50. PMID 10588409 DOI: 10.1176/Ajp.156.12.1944  0.459
1999 Arango C, Bartko JJ, Gold JM, Buchanan RW. Prediction of neuropsychological performance by neurological signs in schizophrenia. The American Journal of Psychiatry. 156: 1349-57. PMID 10484944 DOI: 10.1176/Ajp.156.9.1349  0.384
1999 Bellack AS, Gold JM, Buchanan RW. Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies. Schizophrenia Bulletin. 25: 257-74. PMID 10416730 DOI: 10.1093/Oxfordjournals.Schbul.A033377  0.509
1999 Gourovitch ML, Torrey EF, Gold JM, Randolph C, Weinberger DR, Goldberg TE. Neuropsychological performance of monozygotic twins discordant for bipolar disorder Biological Psychiatry. 45: 639-646. PMID 10088052 DOI: 10.1016/S0006-3223(98)00148-6  0.342
1999 Gold J. Schizophrenia From a Neurocognitive Perspective: Probing the Impenetrable Darkness. The Journal of Nervous & Mental Disease. 187: 192-193. DOI: 10.1097/00005053-199903000-00011  0.387
1998 Gold J, David A, Stevens JR, Stevens CM, Wyatt RJ, Russell AJ, Murray RM. Schizophrenia and intellectual decline [14] (multiple letters) American Journal of Psychiatry. 155: 1633-1637. PMID 9812144 DOI: 10.1176/Ajp.155.11.1626M  0.419
1998 Tamminga CA, Buchanan RW, Gold JM. The role of negative symptoms and cognitive dysfunction in schizophrenia outcome. International Clinical Psychopharmacology. S21-6. PMID 9690966 DOI: 10.1097/00004850-199803003-00004  0.398
1998 Binks SW, Gold JM. Differential Cognitive Deficits in the Neuropsychology of Schizophrenia The Clinical Neuropsychologist. 12: 8-20. DOI: 10.1076/Clin.12.1.8.1730  0.448
1997 Goldberg TE, Gold JM, Coppola R, Weinberger DR. Unnatural practices, unspeakable actions: A study of delayed auditory feedback in schizophrenia American Journal of Psychiatry. 154: 858-860. PMID 9167517 DOI: 10.1176/Ajp.154.6.858  0.362
1997 Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR. Auditory working memory and Wisconsin card sorting test performance in schizophrenia Archives of General Psychiatry. 54: 159-165. PMID 9040284 DOI: 10.1001/Archpsyc.1997.01830140071013  0.445
1997 Gold JM, Bryant NL, Vladar K, Buchanan RW. Successful vocational functioning in schizophrenia Schizophrenia Research. 24: 222. DOI: 10.1016/S0920-9964(97)82638-2  0.399
1997 Bustillo J, Gold J, Thaker G, Buchanan R. Inhibition of return in schizophrenia Schizophrenia Research. 24: 99. DOI: 10.1016/S0920-9964(97)82269-4  0.369
1995 Goldberg TE, Torrey EF, Gold JM, Bigelow LB, Ragland RD, Taylor E, Weinberger DR. Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophrenia Research. 17: 77-84. PMID 8541253 DOI: 10.1016/0920-9964(95)00032-H  0.437
1995 Gold JM, Blaxton TA, Hermann BP, Randolph C, Fedio P, Goldberg TE, Theodore WH, Weinberger DR. Memory and intelligence in lateralized temporal lobe epilepsy and schizophrenia. Schizophrenia Research. 17: 59-65. PMID 8541251 DOI: 10.1016/0920-9964(95)00030-P  0.319
1995 Goldberg TE, Gold JM, Torrey EF, Weinberger DR. Lack of sex differences in the neuropsychological performance of patients with schizophrenia American Journal of Psychiatry. 152: 883-888. PMID 7755118 DOI: 10.1176/Ajp.152.6.883  0.329
1995 Fleming K, Goldberg TE, Gold JM, Weinberger DR. Verbal working memory dysfunction in schizophrenia: use of a Brown-Peterson paradigm Psychiatry Research. 56: 155-161. PMID 7667440 DOI: 10.1016/0165-1781(95)02589-3  0.369
1995 Gold JM, Weinberger DR. Cognitive deficits and the neurobiology of schizophrenia. Current Opinion in Neurobiology. 5: 225-30. PMID 7620311 DOI: 10.1016/0959-4388(95)80030-1  0.466
1995 Goldberg TE, Gold JM, Fuller Torrey E, Weinberger DR. Sex differences and neurocognition in schizophrenia Schizophrenia Research. 15: 118. DOI: 10.1016/0920-9964(95)95363-E  0.39
1994 Gold JM, Hermann BP, Randolph C, Wyler AR, Goldberg TE, Weinberger DR. Schizophrenia and Temporal Lobe Epilepsy: A Neuropsychological Analysis Archives of General Psychiatry. 51: 265-272. PMID 8161286 DOI: 10.1001/Archpsyc.1994.03950040009001  0.434
1994 Gold J, Blaxton T, Hermann B, Goldberg T, Wyler A, Theodore W, Weinberger D. Neuropsychological differences between schizophrenia and temporal lobe epilepsy Biological Psychiatry. 35: 635. DOI: 10.1016/0006-3223(94)90730-7  0.329
1993 Torrey EF, Ragland JD, Gold JM, Goldberg TE, Bowler AE, Bigelow LB, Gottesman II. Handedness in twins with schizophrenia: was Boklage correct? Schizophrenia Research. 9: 83-5. PMID 8461274 DOI: 10.1016/0920-9964(93)90014-A  0.336
1993 Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, Kleinman JE, Pickar D, Schulz SC, Weinberger DR. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 162: 43-8. PMID 8425138 DOI: 10.1192/Bjp.162.1.43  0.486
1993 Goldberg TE, Gold JM, Greenberg R, Griffin S, Schulz SC, Pickar D, Kleinman JE, Weinberger DR. Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. The American Journal of Psychiatry. 150: 1355-62. PMID 8352346 DOI: 10.1176/ajp.150.9.1355  0.442
1993 Casanova MF, Carosella NW, Gold JM, Kleinman JE, Weinberger DR, Powers RE. A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia. Psychiatry Research. 49: 41-62. PMID 8140181 DOI: 10.1016/0165-1781(93)90029-G  0.35
1993 Gold JM, Harvey PD. Cognitive Deficits in Schizophrenia Psychiatric Clinics of North America. 16: 295-312. DOI: 10.1016/S0193-953X(18)30175-8  0.495
1993 Goldberg T, Nowlin B, Gold J, Weinberger D. Remote memory in schizophrenia Schizophrenia Research. 9: 175. DOI: 10.1016/0920-9964(93)90340-O  0.333
1993 Goldberg T, Weinberger D, Gold J, Greenberg R, Griffin S, Schulz S, Pickar D, Kleinman J. Neuropsychological specificity and schizophrenia: A comparison with affective groups Schizophrenia Research. 9: 175. DOI: 10.1016/0920-9964(93)90339-K  0.404
1992 Gold JM, Randolph C, Carpenter CJ, Goldberg TE, Weinberger DR. The performance of patients with schizophrenia on the wechsler memory scale-revised Clinical Neuropsychologist. 6: 367-373. DOI: 10.1080/13854049208401864  0.301
1992 Gold JM, Randolph C, Carpenter CJ, Goldberg TE, Weinberger DR. Forms of memory failure in schizophrenia. Journal of Abnormal Psychology. 101: 487-494. DOI: 10.1037/0021-843X.101.3.487  0.305
1991 Gold JM, Egan MF, Kirch DG, Goldberg TE, Daniel DG, Bigelow LB, Wyatt RJ. Tardive dyskinesia: neuropsychological, computerized tomographic, and psychiatric symptom findings. Biological Psychiatry. 30: 587-99. PMID 1681948 DOI: 10.1016/0006-3223(91)90028-K  0.342
1991 Stevens JR, Gold JM. What is schizophrenia? Behavioral and Brain Sciences. 14: 50-51. DOI: 10.1017/S0140525X00065377  0.397
1991 Randolph C, Gold J, Goldberg T, Weinberger D. Implicit memory function in schizophrenia Schizophrenia Research. 4: 391. DOI: 10.1016/0920-9964(91)90333-M  0.338
1991 Greenberg R, Goldberg T, Griffin S, Gold J, Kleinman J, Pickar D, Weinberger D. Effects of clozapine on cognition in patients with schizophrenia Schizophrenia Research. 4: 385. DOI: 10.1016/0920-9964(91)90322-I  0.511
1991 Goldberg T, Torrey E, Gold J, Ragland J, Bigelow L, Weinberger B. Memory function in monozygotic twins discordant for schizophrenia Schizophrenia Research. 4: 384. DOI: 10.1016/0920-9964(91)90320-Q  0.343
1991 Gold J, Randolph C, Carpenter C, Goldberg T, Weinberger D. Forms of memory failure in schizophrenia Schizophrenia Research. 4: 383-384. DOI: 10.1016/0920-9964(91)90319-M  0.305
1990 Goldberg TE, Ragland JD, Torrey EF, Gold JM, Bigelow LB, Weinberger DR. Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Archives of General Psychiatry. 47: 1066-72. PMID 2241508 DOI: 10.1001/Archpsyc.1990.01810230082013  0.376
1990 Gold JM, Hurt SW. The effects of haloperidol on thought disorder and IQ in schizophrenia. Journal of Personality Assessment. 54: 390-400. PMID 2179521 DOI: 10.1080/00223891.1990.9674002  0.374
1989 Gold J, Egan M, Goldberg T, Kirch D. Cognitive impairment and tardive dyskinesia Schizophrenia Research. 2: 236. DOI: 10.1016/0920-9964(89)90272-7  0.356
1988 Medalia A, Gold J, Merriam A. The effects of neuroleptics on neuropsychological test results of schizophrenics Archives of Clinical Neuropsychology. 3: 249-271. DOI: 10.1093/Arclin/3.3.249  0.391
1974 Gold JR, Green MM. A meiotic effect of a mutator gene in Drosophila melanogaster. Molecular & General Genetics : Mgg. 135: 245-55. PMID 4218303 DOI: 10.1007/BF00268619  0.35
Show low-probability matches.